Use and misuse of biomarkers and the role of D-dimer and C-reactive protein in the management of COVID-19: A post-hoc analysis of a prospective cohort study.
Gonçalves FAR, Besen BAMP, Lima CA, Corá AP, Pereira AJR, Perazzio SF, Gouvea CP, Fonseca LAM, Trindade EM, Sumita NM, Duarte AJDS, Lichtenstein A; HCFMUSP COVID-19 Study Group; Bonfa E, Utiyama EM, Segurado AC, Perondi B, Miethke-Morais A, Montal AC, Harima L, Fusco SRG, Silva MF, Rocha MC, Marcilio I, Rios IC, Kawano FYO, Jesus MA, Kallas ÉG, Carmo C, Tanaka C, Souza HP, Marchini JFM, Carvalho C, Ferreira JC, Levin ASS, Oliveira MS, Guimarães T, Lázari CDS, Sabino E, Magri MMC, Barros-Filho TEP, Francisco MCPB, Costa SF.
Gonçalves FAR, et al. Among authors: perondi b.
Clinics (Sao Paulo). 2021 Dec 8;76:e3547. doi: 10.6061/clinics/2021/e3547. eCollection 2021.
Clinics (Sao Paulo). 2021.
PMID: 34909913
Free PMC article.